Skeletal Radiology

, Volume 41, Issue 10, pp 1263–1272 | Cite as

Imaging features of low-grade fibromyxoid sarcoma (Evans tumor)

Scientific Article



To determine common imaging features of low-grade fibromyxoid sarcoma (LGFMS), a rare subtype of fibrosarcoma with a benign histological appearance but with a propensity for local recurrence and metastasis.

Materials and methods

By review of medical records, 29 patients (14 males, 15 females) with mean age of 41 years (range, 11–64 years) with diagnosis of LGFMS and imaging available in PACS were identified. The study included radiography (9/29), ultrasound (1/29), CT (14/29), and MRI (22/29). Imaging features evaluated included anatomic site, and lesion size, number, location, US echogenicity, CT attenuation, calcifications, MR signal intensity pattern, and contrast enhancement.


Twenty-two patients had imaging at initial diagnosis, and seven had imaging only at local recurrence. The majority of tumors (27/29) were deep in tissue, with mean size of 6.2 cm (range, 1.4–19.0 cm). Tumor was single at initial diagnosis and multiple at local recurrence; lower extremity was the most common site. On radiographs, tumor was visible in four of nine without bone erosion or calcification. Areas of CT attenuation hypodense to muscle were seen in 13/14 patients. Calcification was uncommon (3/14). On fluid-sensitive MRI sequences, the predominant signal intensity was hyperintense to muscle in 11/21 patients. In 13/21 patients, tumor displayed either a brain gyriform pattern of alternating hypointense and hyperintense signal intensity (9/13) or intralesional nodules (3/13); 1 case had both patterns. On US tumor was solid with heterogeneous echogenicity.


LGFMS is commonly single at initial diagnosis and multiple at local recurrence. LGFMS frequently shows areas of CT attenuation hypodense to muscle and gyriform patterns of signal intensity and contrast enhancement at MRI.


Low-grade fibromyxoid sarcoma Evans tumor Soft tissue CT MRI 


  1. 1.
    Antonescu CR, Baren A. Spectrum of low-grade fibrosarcomas: a comparative ultrastructural analysis of low-grade myxofibrosarcoma and fibromyxoid sarcoma. Ultrastruct Pathol. 2004;28:321–32.PubMedCrossRefGoogle Scholar
  2. 2.
    Folpe AL, Lane KL, Paull G, Weiss SW. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol. 2000;24:1353–60.PubMedCrossRefGoogle Scholar
  3. 3.
    Evans HL. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. Am J Surg Pathol. 2011;35:1450–62.PubMedCrossRefGoogle Scholar
  4. 4.
    Goodlad JR, Mentzel T, Fletcher CD. Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity. Histopathology. 1995;26:229–37.PubMedCrossRefGoogle Scholar
  5. 5.
    Billings SD, Giblen G, Fanburg-Smith JC. Superficial low-grade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol. 2005;29:204–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Doyle LA, Möller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2011;35:733–41.PubMedCrossRefGoogle Scholar
  7. 7.
    Mertens F, Fletcher CD, Antonescu CR, Coindre JM, Colecchia M, Domanski HA, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005;85:408–15.PubMedCrossRefGoogle Scholar
  8. 8.
    Kim SK, Jee WH, Lee AW, Chung YG. Haemorrhagic low-grade fibromyxoid sarcoma: MR findings in two young women. Br J Radiol. 2011;84:e146–50.PubMedCrossRefGoogle Scholar
  9. 9.
    Fujii S, Kawawa Y, Horiguchi S, Kamata N, Kinoshita T, Ogawa T. Low-grade fibromyxoid sarcoma of the small bowel mesentery: computed tomography and magnetic resonance imaging findings. Radiat Med. 2008;26:244–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Miyake M, Tateishi U, Maeda T, Arai Y, Seki K, Hasegawa T, et al. CT and MRI features of low-grade fibromyxoid sarcoma in the shoulder of a pediatric patient. Radiat Med. 2006;24:511–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Lee AF, Yip S, Smith AC, Hayes MM, Nielsen TO, O'Connell JX. Low-grade fibromyxoid sarcoma of the perineum with heterotopic ossification: case report and review of the literature. Hum Pathol. 2011;42(11):1770–5.CrossRefGoogle Scholar
  12. 12.
    Koh SH, Choe HS, Lee IJ, Park HR, Bae SH. Low-grade fibromyxoid sarcoma: ultrasound and magnetic resonance findings in two cases. Skeletal Radiol. 2005;34:550–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Dinauer PA, Brixey CJ, Moncur JT, Fanburg-Smith JC, Murphey MD. Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults. Radiographics. 2007;27(1):173–87.PubMedCrossRefGoogle Scholar
  14. 14.
    Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics. 2003;23(2):283–304, 456; quiz 532.Google Scholar
  15. 15.
    Garcia-Bennett J, Olivé CS, Rivas A, Domínguez-Oronoz R, Huguet P. Soft tissue solitary fibrous tumor. Imaging findings in a series of nine cases. Skeletal Radiol. 2012. doi:10.1007/s00256-012-1364-y
  16. 16.
    Kaya M, Wada T, Nagoya S, Sasaki M, Matsumura T, Yamaguchi T, et al. MRI and histological evaluation of the infiltrative growth pattern of myxofibrosarcoma. Skeletal Radiol. 2008;37(12):1085–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Waters B, Panicek DM, Lefkowitz RA, Antonescu CR, Healey JH, Athanasian EA, et al. Low-grade myxofibrosarcoma: CT and MRI patterns in recurrent disease. AJR Am J Roentgenol. 2007;188(2):W193–8.PubMedCrossRefGoogle Scholar

Copyright information

© ISS 2012

Authors and Affiliations

  1. 1.Department of RadiologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Department of RadiologyChildren’s Hospital BostonBostonUSA
  3. 3.Department of PathologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations